HB4692 - Cannabis Warning Labels

• Requires medical cannabis infused products and harvested cannabis to include warning labels stating potential side effects on packaging, with wording determined by the Department of Public Health through administrative rulemaking.

• Mandates cultivation centers place warning labels on all harvested cannabis intended for distribution to dispensing organizations.

• Prohibits dispensing organizations from selling any medical cannabis product unless the container displays a warning label regarding potential side effects.

• Applies to both infused products (brownies, tinctures, etc.) and raw cannabis, ensuring consistent labeling across the supply chain from cultivation to patient purchase.

• Takes effect January 1, 2017.